By Professor Dedee Frances Murrell

Journal articles

Murrell DF; Caux F; Prost-Squarcioni C, 2018, 'Is the Oral Disease Severity Score going to be useful for dermatologists when assessing pemphigus?', British Journal of Dermatology, 179, pp. 816 - 817, http://dx.doi.org/10.1111/bjd.16911

De Brito M; Huebner G; Murrell D; Bullpitt P; Hartmann K, 2018, 'Normocomplementaemic urticarial vasculitis: Effective treatment with omalizumab', Clinical and Translational Allergy, 8, http://dx.doi.org/10.1186/s13601-018-0222-y

Yang A; Uhlenhake E; Murrell DF, 2018, 'Pemphigoid gestationis and intravenous immunoglobulin therapy', International Journal of Women's Dermatology, 4, pp. 166 - 169, http://dx.doi.org/10.1016/j.ijwd.2018.03.007

Wang EQ; Castrillón Velásquez MA; Murrell DF, 2018, 'The effects of autoimmune blistering diseases on work productivity: A review', International Journal of Women's Dermatology, 4, pp. 131 - 138, http://dx.doi.org/10.1016/j.ijwd.2017.11.001

Cho RJ; Alexandrov LB; Den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP, 2018, 'APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa', Science Translational Medicine, 10, http://dx.doi.org/10.1126/scitranslmed.aas9668

Chen G; Yang B; Zhang Z; Yang Q; Yan X; Murrell DF; Zhang F, 2018, 'Chinese version of the treatment of autoimmune bullous disease quality of life questionnaire: Reliability and validity', Indian Journal of Dermatology, Venereology and Leprology, 84, pp. 431 - 436, http://dx.doi.org/10.4103/ijdvl.ijdvl_538_16

Prost-Squarcioni C; Caux F; Schmidt E; Jonkman MF; Vassileva S; Kim SC; Iranzo P; Daneshpazhooh M; Terra J; Bauer J; Fairley J; Hall R; Hertl M; Lehman JS; Marinovic B; Patsatsi A; Zillikens D; Werth V; Woodley DT; Murrell DF, 2018, 'International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita', British Journal of Dermatology, 179, pp. 30 - 41, http://dx.doi.org/10.1111/bjd.16138

Xuan RR; Yang A; Murrell DF, 2018, 'New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature', International Journal of Women's Dermatology, 4, pp. 102 - 108, http://dx.doi.org/10.1016/j.ijwd.2017.10.001

Lee BWH; Tan JCK; Radjenovic M; Coroneo MT; Murrell DF, 2018, 'A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases', Orphanet Journal of Rare Diseases, 13, pp. 83, http://dx.doi.org/10.1186/s13023-018-0823-5

Chen J; Yang A; Murrell D, 2018, 'Osteopenia is common in mild forms of epidermolysis bullosa', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138, pp. S45 - S45, http://dx.doi.org/10.1016/j.jid.2018.03.271

Xuan RR; Yang A; Melbourne W; Hashimoto T; Uzun S; Daneshpazhooh M; Yamagami J; Di Zenzo G; Mascaro J; Murrell D, 2018, 'Reliability of the BIOCHIP in pemphigus and pemphigoid patients the evaluations of blistering disease experts', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138, pp. S10 - S10, http://dx.doi.org/10.1016/j.jid.2018.03.063

Yang A; Chin R; Murrell DF, 2018, 'Mucous membrane pemphigoid affecting the epiglottis and response to intravenous immunoglobulin therapy', Otolaryngology Case Reports, 6, pp. 1 - 3, http://dx.doi.org/10.1016/j.xocr.2017.11.001

Jain SV; Murrell DF, 2018, 'Psychosocial impact of inherited and autoimmune blistering diseases', International Journal of Women's Dermatology, 4, pp. 49 - 53, http://dx.doi.org/10.1016/j.ijwd.2017.11.004

Drucker AM; Eyerich K; de Bruin-Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman-Yassky E, 2018, 'Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement', British Journal of Dermatology, 178, pp. 768 - 775, http://dx.doi.org/10.1111/bjd.15928

Bauer JW; Paller A; Mellerio JE; Hovnanian A; Pan JJ; Zografaos P; Licholai GP; Murrell DF, 2018, 'Use of an Investigator's Global Assessment Scale to Evaluate Disease Severity in Patients swith Epidermolysis Bullosa Simplex', SKIN The Journal of Cutaneous Medicine, 2, pp. S55 - S55, http://dx.doi.org/10.25251/skin.2.supp.55

Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L, 2018, 'Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management', Clinical Reviews in Allergy and Immunology, 54, pp. 26 - 51, http://dx.doi.org/10.1007/s12016-017-8633-4

Yang A; Kim M; Craig P; Murrell DF, 2018, 'A case report of the use of rituximab and the epidermolysis bullosa disease activity scoring index (EBDASI) in a patient with epidermolysis bullosa acquisita with extensive esophageal involvement', Acta Dermatovenerologica Croatica, 26, pp. 325 - 328

Kim M; Li M; Intong-Wheeler LRA; Tran K; Marucci D; Murrell DF, 2018, 'Epidemiology and outcome of squamous cell carcinoma in epidermolysis bullosa in Australia and New Zealand', Acta Dermato-Venereologica, 98, pp. 70 - 76, http://dx.doi.org/10.2340/00015555-2781

Lee J; Werth VP; Hall RP; Eming R; Fairley JA; Fajgenbaum DC; Harman KE; Jonkman MF; Korman NJ; Ludwig RJ; Murrell DF; Musette P; Naik HB; Sadik CD; Yamagami J; Yale ML; Payne AS, 2018, 'Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference', Frontiers in Medicine, 5, http://dx.doi.org/10.3389/fmed.2018.00306

Murrell D; Paller A; Bodemer C; Barth JA; Lagast H; Reha A, 2018, '585 Natural history of wound closure and other clinical endpoints in epidermolysis bullosa: Lessons from a 90-day multicenter trial', Journal of Investigative Dermatology, 138, pp. S99 - S99, http://dx.doi.org/10.1016/j.jid.2018.03.593

Murrell DF; Daneshpahzooh M; Meymandi S; Wiest LG, 2018, 'International chapters and membership of WDS are growing', International Journal of Women's Dermatology, 4, pp. 240 - 240, http://dx.doi.org/10.1016/j.ijwd.2018.10.005

Murrell D; Stavropoulos P; Patsatsi A; Zeeli T; Baum S; Bassukas I; Caux F; Roussaki A; Sinclair R; Kern J; Gourlay S; Joly P, 2018, 'LB1509 Anti-desmoglein levels & response to the BTK inhibitor PRN1008 in pemphigus', Journal of Investigative Dermatology, 138, pp. B7 - B7, http://dx.doi.org/10.1016/j.jid.2018.06.040

Drucker AM; Eyerich K; de Bruin-Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman-Yassky E, 2018, 'Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement', British Journal of Dermatology, 178, pp. e232 - e232, http://dx.doi.org/10.1111/bjd.16385

Drucker AM; Eyerich K; de Bruin-Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman-Yassky E, 2018, '对过敏性皮肤炎使用全身用糖皮质激素:国际湿疹理事会共识声明', British Journal of Dermatology, 178, pp. e246 - e246, http://dx.doi.org/10.1111/bjd.16452

Frew JW; Davidson M; Murrell DF, 2017, 'Disease-specific health related quality of life patient reported outcome measures in Genodermatoses: A systematic review and critical evaluation', Orphanet Journal of Rare Diseases, 12, pp. 189, http://dx.doi.org/10.1186/s13023-017-0739-5

Gollins CE; Shipman AR; Murrell DF, 2017, 'A study of the number of female editors-in-chief of dermatology journals', International Journal of Women's Dermatology, 3, pp. 185 - 188, http://dx.doi.org/10.1016/j.ijwd.2017.03.001

Murrell D, 2017, 'New developments in the management of congenital epidermolysis bullosa', Annales de Dermatologie et de Venereologie, 144, pp. S6 - S7, http://dx.doi.org/10.1016/j.annder.2017.09.587

Murrell DF; Sprecher E, 2017, 'Rituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus', British Journal of Dermatology, 177, pp. 1143 - 1144, http://dx.doi.org/10.1111/bjd.15947

Kim EN; Harris AG; Bingham LJ; Yan W; Su JC; Murrell DF, 2017, 'A review of 52 pedigrees with epidermolysis bullosa simplex identifying ten novel mutations in KRT5 and KRT14 in Australia', Acta Dermato-Venereologica, 97, pp. 1114 - 1119, http://dx.doi.org/10.2340/00015555-2715

Frew JW; Murrell DF, 2017, 'Highly Resistant Acrodermatitis Continua of Hallopeau and Pustular Psoriasis', Skin Appendage Disorders, 3, pp. 179 - 181, http://dx.doi.org/10.1159/000464140

Patsatsi A; Kokolios M; Kyriakou A; Lamprou F; Stylianidou D; Tsapas A; Goulis DG; Murrell DF; Sotiriadis D, 2017, 'Quality of life in greek patients with autoimmune bullous diseases assessed with ABQOL and TABQOL indexes', Acta Dermato-Venereologica, 97, pp. 1145 - 1147, http://dx.doi.org/10.2340/00015555-2737

Murrell DF; Grant-Kels J, 2017, 'The International Journal of Women's Dermatology is now listed on PubMed Central', International Journal of Women's Dermatology, 3, pp. 126, http://dx.doi.org/10.1016/j.ijwd.2017.06.003

Kim E; Harris A; Hyland V; Murrell DF, 2017, 'Digenic inheritance in epidermolysis bullosa simplex involving two novel mutations in KRT5 and KRT14', British Journal of Dermatology, 177, pp. 262 - 264, http://dx.doi.org/10.1111/bjd.15053

Castrillón MA; Murrell DF, 2017, 'Lupus profundus limited to a site of trauma: Case report and review of the literature', International Journal of Women's Dermatology, 3, pp. 117 - 120, http://dx.doi.org/10.1016/j.ijwd.2017.03.002

Patsatsi A; Murrell DF, 2017, 'Multiple sclerosis is the neurological disorder most highly associated with bullous pemphigoid', British Journal of Dermatology, 176, pp. 1428 - 1429, http://dx.doi.org/10.1111/bjd.15581

Sekulic A; Migden MR; Basset-Seguin N; Garbe C; Gesierich A; Lao CD; Miller C; Mortier L; Murrell DF; Hamid O; Quevedo JF; Hou J; McKenna E; Dimier N; Williams S; Schadendorf D; Hauschild A, 2017, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study', BMC Cancer, 17, pp. 332, http://dx.doi.org/10.1186/s12885-017-3286-5

Cheape AC; Murrell DF, 2017, '2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis', Expert Review of Clinical Immunology, 13, pp. 415 - 423, http://dx.doi.org/10.1080/1744666X.2017.1304820

Smithson SL; Rademaker M; Adams S; Bade S; Bekhor P; Davidson S; Dore A; Drummond C; Fischer G; Gin A; Grills C; Halbert A; Lokmic Z; McCahon E; Morgan VA; Murrell DF; Orchard D; Penington A; Purvis D; Relic J; Robertson S; Robinson AJ; Scardamaglia L; Su J; Tan S; Wargon O; Warren L; Wong LC; Zappala T; Phillips R, 2017, 'Consensus statement for the treatment of infantile haemangiomas with propranolol', Australasian Journal of Dermatology, 58, pp. 155 - 159, http://dx.doi.org/10.1111/ajd.12600

van Beek N; Dähnrich C; Johannsen N; Lemcke S; Goletz S; Hübner F; Di Zenzo G; Dmochowski M; Drenovska K; Geller S; Horn M; Kowalewski C; Medenica L; Murrell DF; Patsatsi A; Uzun S; Vassileva S; Zillikens D; Schlumberger W; Schmidt E, 2017, 'Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases', Journal of the American Academy of Dermatology, 76, pp. 889 - 894.e5, http://dx.doi.org/10.1016/j.jaad.2016.11.002

Harris AG; Todes-Taylor NR; Petrović N; Murrell DF, 2017, 'The distribution of epidermolysis bullosa in Australia with a focus on rural and remote areas', Australasian Journal of Dermatology, 58, pp. 122 - 125, http://dx.doi.org/10.1111/ajd.12431

Zhao CY; Hao EY; Oh DD; Daniel BS; Martin LK; Su JC; Rodrigues M; Murrell DF, 2017, 'A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients', British Journal of Dermatology, 176, pp. 985 - 992, http://dx.doi.org/10.1111/bjd.15271

Jain SV; Harris AG; Su JC; Orchard D; Warren LJ; McManus H; Murrell DF, 2017, 'The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 31, pp. 692 - 698, http://dx.doi.org/10.1111/jdv.13953

Miloslavsky EM; Naden RP; Bijlsma JWJ; Brogan PA; Brown ES; Brunetta P; Buttgereit F; Choi HK; Dicaire JF; Gelfand JM; Heaney LG; Lightstone L; Lu N; Murrell DF; Petri M; Rosenbaum JT; Saag KS; Urowitz MB; Winthrop KL; Stone JH, 2017, 'Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis', Annals of the Rheumatic Diseases, 76, pp. 543 - 546, http://dx.doi.org/10.1136/annrheumdis-2016-210002

Cust AE; Murrell DF, 2017, 'Increasing prevalence but not incidence of psoriasis in the U.K.', British Journal of Dermatology, 176, pp. 568 - 569, http://dx.doi.org/10.1111/bjd.15331

Kalinska-Bienias A; Jakubowska B; Kowalewski C; Murrell DF; Wozniak K, 2017, 'Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease – specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires', Advances in Medical Sciences, 62, pp. 92 - 96, http://dx.doi.org/10.1016/j.advms.2016.07.002

Intong LRA; Choi SD; Shipman A; Kho YC; Hwang SJE; Rhodes LM; Walton JR; Chapman MG; Murrell DF, 2017, 'Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand', International Journal of Women's Dermatology, 3, pp. S1 - S5, http://dx.doi.org/10.1016/j.ijwd.2017.02.002

Yang B; Chen G; Yang Q; Yan X; Zhang Z; Murrell DF; Zhang F, 2017, 'Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQOL) questionnaire', Health and Quality of Life Outcomes, 15, pp. 31, http://dx.doi.org/10.1186/s12955-017-0594-z

Wijayanti A; Zhao CY; Boettiger D; Chiang YZ; Ishii N; Hashimoto T; Murrell DF, 2017, 'The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for bullous pemphigoid: Which one to use?', Acta Dermato-Venereologica, 97, pp. 24 - 31, http://dx.doi.org/10.2340/00015555-2473

Stalder JF; Aubert H; Anthoine E; Futamura M; Marcoux D; Morren MA; Trzeciak M; Szalai Z; Veres K; Deleuran M; Vestergaard C; Boralevi F; Chu CY; De Raeve L; Svensson ; Fölster-Holst R; Buchner M; Takaoka R; Aoki V; Chernyshov P; Chernyshova L; Murrell DF; Zhao C; Mckinster CD; Von Kobyletzky L; Eichenfield L; Totri C; Lio P; Seneschal J; Moret L; Barbarot S, 2017, 'Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score', Allergy: European Journal of Allergy and Clinical Immunology, 72, pp. 1713 - 1719, http://dx.doi.org/10.1111/all.13189

Murrell DF, 2017, 'Why have hospitalization rates for bullous pemphigoid soared?', British Journal of Dermatology, 176, pp. 5 - 6, http://dx.doi.org/10.1111/bjd.15190

Back to profile page